Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on November 5, 2007
Schizophrenia Bulletin 2008 34(1):13-14; doi:10.1093/schbul/sbm126
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/1/13    most recent
sbm126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Almerie, M. Q.
Right arrow Articles by Rezk, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almerie, M. Q.
Right arrow Articles by Rezk, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Cessation of Medication for People With Schizophrenia Already Stable on Chlorpromazine

Muhammad Qutayba Almerie1,2, Hosam El-Din Matar2, Adib Essali2, Hassan Alkhateeb3 and Emtithal Rezk2
2 The Continuing Professional Development Centre, Mezzah, Shaikh Saad, PO Box 11719, Damascus, Syria
3 Damascus Faculty of Medicine, Mezzah Avenue, Damascus, Syria

Keywords: schizophrenia / chlorpromazine / cessation

The first 10% of the full text of this article appears below.


   Introduction
 
People with schizophrenia are often encouraged to take medication for protracted periods of time in order to postpone or stop deterioration. It is, nevertheless, difficult for clinicians to provide a quantitative estimate of risk of relapse should medication be stopped. Because protracted use of any medication carries a risk of adverse effects, . . . [Full Text of this Article]


   Objectives
 

   Search Strategy
 

   Selection Criteria
 

   Data Collection and Analysis
 

   Results
 

   Reviewer's Conclusion
 

   Implications for Practice
 

   Implications for Research
 
1 To whom correspondence should be addressed; tel: +963-11-666-6223, fax: +963-11-461-9902, e-mail: qutaybah83@hotmail.com.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?